Short-term control of diet affects cisplatin-induced acute kidney injury through modulation of mitochondrial dynamics and mitochondrial GSH

被引:6
作者
Kim, Ji Su [1 ,2 ]
Han, Yong Kwon [1 ,2 ]
Kong, Min Jung [1 ,2 ,3 ]
Park, Kwon Moo [1 ,2 ,3 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Dept Anat, Daegu 41944, South Korea
[2] Kyungpook Natl Univ, BK21 Plus, Sch Med, Daegu, South Korea
[3] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea
来源
PHYSIOLOGICAL REPORTS | 2022年 / 10卷 / 12期
基金
新加坡国家研究基金会;
关键词
acute kidney injury; apoptosis; cisplatin; fasting; high-fat diet; mitochondrial damage; oxidative stress; INDUCED CELL-DEATH; INDUCED NEPHROTOXICITY; CALORIE RESTRICTION; OXIDATIVE STRESS; CANCER-CHEMOTHERAPY; INDUCED TOXICITY; SUPPLEMENTATION; INFLAMMATION; COMBINATION; RESISTANCE;
D O I
10.14814/phy2.15348
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Obesity affects acute kidney injury (AKI) induced by various clinical settings, including transplantation and cisplatin-cancer therapy. However, the effect of short-term food intake change remains to be defined. Here, we investigated the effects of short-term high-fat diet intake and food restriction on cisplatin-induced AKI. Mice were fed either a high-fat diet (HFD) or a low-fat diet (LFD) for 11 days or were not fed for 40 hh (fasting), before cisplatin administration. Cisplatin-induced functional and structural damages to kidneys in both H FD- and LFD-fed mice, with greater damages in HFD-fed mice than LFD-fed mice. HFD decreased mitochondrial total glutathione (tGSH) level, along with increases in the plasma and kidney cholesterol levels. Cisplatin caused the increase of kidney cholesterol levels and oxidative stress, along with the decrease of mitochondrial tGSH levels. In addition, cisplatin-induced mitochondrial damage and apoptosis of tubular cells in both HFD- and LFD-fed mice. An increase of Fisi (mitochondria fission 1 protein), whereas a decrease of Opal (mitochondria fusion 1 protein) occurred by cisplatin. These cisplatin effects were greater in HFD-fed mice than in LFD-fed mice. Administration of mitochondria-specific antioxidant treatment during HFD feeding inhibited these cisplatin-induced changes. Fasting for 40h also significantly reduced the cisplatin-induced changes mentioned above. These data demonstrate that short-term HFD intake worsens cisplatin-induced oxidative stress by the reduction of mitochondrial tGSH, resulting in increased cisplatin-induced nephrotoxicity. These data newly indicate that the control of calorie intake, even for a short period, affects kidney susceptibility to injury. Although most studies described the effects of a long-term high-fat diet on the kidneys, in this study, we found that even if a high-fat diet was consumed for a short-term, physiological changes and mitochondria tGSH decrease in the kidneys, and consequently increased cisplatin-nephrotoxic susceptibility. These data suggest the association of calorie intake with kidney susceptibility to cisplatin.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Limonin mitigates cisplatin-induced acute kidney injury through metabolic reprogramming
    Zeng, Xi
    Zhou, Xianke
    Zhou, Jiayi
    Zhou, Hong
    Hong, Xue
    Li, Dier
    Xiang, Yadie
    Zhong, Menghua
    Chen, Yudan
    Liang, Dongning
    Fu, Haiyan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [32] Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
    Xie, Wenjia
    He, Qingyun
    Zhang, Yan
    Xu, Xinxin
    Wen, Ping
    Cao, Hongdi
    Zhou, Yang
    Luo, Jing
    Yang, Junwei
    Jiang, Lei
    CELL DEATH & DISEASE, 2023, 14 (10)
  • [33] TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy
    Yu, Binfeng
    Jin, Lini
    Yao, Xi
    Zhang, Yi
    Zhang, Gensheng
    Wang, Fangqin
    Su, Xinwan
    Fang, Qiuyuan
    Xiao, Liang
    Yang, Yi
    Jiang, Lin-Hua
    Chen, Jianghua
    Yang, Wei
    Lin, Weiqiang
    Han, Fei
    THERANOSTICS, 2023, 13 (13): : 4356 - 4375
  • [34] Melatonin Attenuates Cisplatin-Induced Acute Kidney Injury through Dual Suppression of Apoptosis and Necroptosis
    Kim, Jong Woo
    Jo, Jungmin
    Kim, Jung-Yeon
    Choe, Misun
    Leem, Jaechan
    Park, Jae-Hyung
    BIOLOGY-BASEL, 2019, 8 (03):
  • [35] Analysis of spatiotemporal metabolomic dynamics for sensitively monitoring biological alterations in cisplatin-induced acute kidney injury
    Irie, Miho
    Hayakawa, Eisuke
    Fujimura, Yoshinori
    Honda, Youhei
    Setoyama, Daiki
    Wariishi, Hiroyuki
    Hyodo, Fuminori
    Miura, Daisuke
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 496 (01) : 140 - 146
  • [36] Formononetin protects against cisplatin-induced acute kidney injury through activation of the PPARα/Nrf2/HO-1/NQO1 pathway
    Hao, Yan
    Miao, Jie
    Liu, Wenjia
    Peng, Li
    Chen, Yue
    Zhong, Qing
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (02) : 511 - 522
  • [37] Mitochondrial Dysfunction-Evoked DHODH Acetylation is Involved in Renal Cell Ferroptosis during Cisplatin-Induced Acute Kidney Injury
    Liang, Nan-Nan
    Guo, Yue-Yue
    Zhang, Xiao-Yi
    Ren, Ya-Hui
    He, Yi-Zhang
    Liu, Zhi-Bing
    Xu, De-Xiang
    Xu, Shen
    ADVANCED SCIENCE, 2024, 11 (43)
  • [38] Magnesium Lithospermate B Protects Against Cisplatin-Induced Acute Kidney Injury via Alleviating Mitochondrial Dysfunction
    Shen, Daoqi
    Guo, Man
    Geng, Xuemei
    Yu, Jinbo
    Zhang, Zhen
    Lin, Jing
    Lin, Pan
    Ding, Xiaoqiang
    Xu, Xialian
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2293 - 2304
  • [39] Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury
    Zhu, Lingling
    Yuan, Yujia
    Yuan, Longhui
    Li, Lan
    Liu, Fei
    Liu, Jingping
    Chen, Younan
    Lu, Yanrong
    Cheng, Jingqiu
    THERANOSTICS, 2020, 10 (13): : 5829 - 5844
  • [40] Evaluations of lipid peroxidation and inflammation in short-term glycerol-induced acute kidney injury in rats
    Nara, Akina
    Yajima, Daisuke
    Nagasawa, Sayaka
    Abe, Hiroko
    Hoshioka, Yumi
    Iwase, Hirotaro
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (11) : 1080 - 1086